Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- Health Minister Mitsui Pledges Seamless Support for New Drug Development
October 22, 2012
- Sales Tax Hike Expected to Hasten Separation of Dispensing from Medical Practice by Sapping Yakka-Saeki
October 19, 2012
- FSA to Determine Whether Infertility Treatment Should Be Covered by Private Insurers
October 19, 2012
- PAFSC’s Second Committee to Review Additional Indication for Afinitor on Oct. 31
October 19, 2012
- PAFSC Committee Recommends Approval for Switch OTC Version of Epadel 2 Years after Frist Review
October 18, 2012
- MHLW’s FY2013 Budget Request Seeks More Funding Aimed at Reducing the Drug Lag Based on Results of Policy Evaluation
October 18, 2012
- MHLW to Compile New Generic Share Goal, Roadmap within FY2012
October 17, 2012
- Generic Substitution Could Save 1.53 Trillion Yen in Healthcare Spending: MOF
October 17, 2012
- Former Health Minister Nagatsuma to Take Over as Chairman of Lower House Committee on Health, Labor and Welfare
October 17, 2012
- Mochida’s Epadel Hastily Added to Review List for PAFSC’s Committee on Non-Prescription Drugs
October 16, 2012
- Gov’t, Municipalities Aim to Conclude Discussions on Funding for 3 Add’l Vaccines by Year End
October 16, 2012
- PAFSC’s 1st Committee to Review 4 Products Including Pfizer’s Toviaz on Oct. 26
October 15, 2012
- MEXT Requests Budget for Boosting Number of Pharmacists, Promoting Generic Use at National University Hospitals
October 15, 2012
- Trilateral Meeting of Health Ministers to Be Postponed After China Cites Inability to Attend
October 15, 2012
- MHLW to Begin Pilot Study on Drug Risk Management Plans for Generics
October 12, 2012
- Discussions on Cost-Effective Assessments Are for Preserving National Health Insurance System: Parliamentary Secretary Umemura
October 11, 2012
- Results of Paper-Based Inspection of Japan’s Application for Membership in PIC/S to Be Reported Next May
October 10, 2012
- Dr Takenaka Tapped as NIBIO Advisor, Committed to Creation of Drug Discovery Network
October 9, 2012
- Senior Vice Minister of Health Sakurai Stresses Need to Rebuild Ties with JMA
October 9, 2012
- Health Minister Mitsui Hopes to Ban All Forms of Dispensing Point Services Including Those Using Credit Cards
October 9, 2012
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…